A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/03/2011	US20110268826 GIP-Increase Inhibitor
11/03/2011	US20110268825 Compositions that include anthocyanidins and methods of use
11/03/2011	US20110268822 Methods for synthesizing kotalanol and stereoisomers and analogues thereof, and novel compounds produced thereby
11/03/2011	US20110268820 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
11/03/2011	US20110268817 Compounds useful for the prevention or treatment of accomodative asthenopia
11/03/2011	US20110268811 Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
11/03/2011	US20110268809 Nicotine-Containing Pharmaceutical Compositions
11/03/2011	US20110268808 Dual-release pharmaceutical suspension
11/03/2011	US20110268807 Biodegradable Microspheres and Methods of Use Thereof
11/03/2011	US20110268806 Antisolvent solidification process
11/03/2011	US20110268803 Lung targeting dual drug delivery system
11/03/2011	US20110268801 Novel compounds and compositions and methods of use
11/03/2011	US20110268800 Unsaturated fatty acids as thrombin inhibitors
11/03/2011	US20110268799 Oral controlled release dosage form
11/03/2011	US20110268798 Orally disntegrating tablets for the treatment of pain
11/03/2011	US20110268797 Multicoated aliskiren formulations
11/03/2011	US20110268796 Pharmaceutical formulations useful in the treatment of insomnia
11/03/2011	US20110268795 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes mellitus, prediabetic symptoms, insulin resistance and related disease states and conditions
11/03/2011	US20110268794 Methods and materials for delivering bile acids
11/03/2011	US20110268793 Kits and methods for nutrition supplementation
11/03/2011	US20110268791 Porous nanoparticle supported lipid bilayer nanostructures
11/03/2011	US20110268787 Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
11/03/2011	US20110268786 Patch production technology
11/03/2011	US20110268785 Propynylaminoindan Transdermal Compositions
11/03/2011	US20110268783 Partially microcellular, selectively hydrophilic composite construct for ocular drug delivery
11/03/2011	US20110268781 Drug eluting composite
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268772 Pharmaceutical composition containing an anionic drug and a production method thereof
11/03/2011	US20110268771 Chewable gelled emulsions
11/03/2011	US20110268770 Chewable gelled emulsions
11/03/2011	US20110268769 Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same
11/03/2011	US20110268763 Polynucleotides that stimulate neutrophils
11/03/2011	US20110268761 Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
11/03/2011	US20110268759 Novel anti-stretch mark active agent, and compositions containing same
11/03/2011	US20110268754 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
11/03/2011	US20110268749 Treatment of cancer via targeting of il-13 receptor-alpha2
11/03/2011	US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011	US20110268747 Stxbp1 as psychiatric biomarker in murine model system and their uses
11/03/2011	US20110268735 Multimeric constructs
11/03/2011	US20110268732 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/03/2011	US20110268731 Methods of treating autoimmune disorders and/or inflammatory disorders
11/03/2011	US20110268729 Treatment of amyotrophic lateral sclerosis by nogo-a-antagonist
11/03/2011	US20110268725 Anti-NGF antibodies for the treatment of various disorders
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268723 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration
11/03/2011	US20110268720 Formulations of 5-fluorocytosine and uses thereof
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268717 Herbal-Based Compositions for Alleviating Symptoms Associated with Autism
11/03/2011	US20110268705 Hdac4, hdac5, hdac6, hdac7, and hif1 alpha modulation of retinal cell survival
11/03/2011	US20110268699 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
11/03/2011	US20110268697 Hepatitis C Virus Inhibitors
11/03/2011	US20110268694 Methods for treating vascular leak syndrome
11/03/2011	US20110268690 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
11/03/2011	US20110268689 Photo-crosslinkable antifouling compositions, films obtained from said compositions, and corresponding uses
11/03/2011	US20110268679 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
11/03/2011	US20110268677 Silicone Paste Compositions
11/03/2011	US20110268669 Composition and method for treating eustachian tube dysfunction
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268662 Functionalized nanoceria composition for ophthalmic treatment
11/03/2011	US20110268659 High shear application in drug delivery
11/03/2011	US20110268657 Compositions and methods for the treatment of tumor of hematopoietic origin
11/03/2011	US20110268654 Compositions and methods for delivering a substance to a biological target
11/03/2011	US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres
11/03/2011	US20110265786 Inhalable Formulations For Treating Pulmonary Hypertension And Methods Of Using Same
11/03/2011	DE102010028365A1 Verwendung einer Phospholipid enthaltenden Zusammensetzung zur Entfernung von subkutanen Fettansammlungen Use of a phospholipid-containing composition for removing subcutaneous fat accumulation
11/03/2011	CA2800891A1 Use of kukoamine a and kukoamine b
11/03/2011	CA2800569A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
11/03/2011	CA2797858A1 Sox9 inhibitors
11/03/2011	CA2797808A1 Piperazinotriazines as pi3k inhibitors for use in the treatment of antiproliferative disorders
11/03/2011	CA2797772A1 Pyrazole compounds as jak inhibitors
11/03/2011	CA2797719A1 Small molecule inhibitors of usp1 deubiquitinating enzyme activity
11/03/2011	CA2797365A1 Orally disintegrating tablet containing acarbose
11/03/2011	CA2796034A1 Nmn modulator
11/03/2011	CA2795544A1 Combination therapy of an afucosylated cd20 antibody with a mtor inhibitor
11/03/2011	CA2795543A1 Chemical compounds
11/03/2011	CA2795304A1 Oral dosage forms
11/03/2011	CA2795275A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
11/03/2011	CA2795218A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/03/2011	CA2794824A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/03/2011	CA2793859A1 Therapeutic agent and preventative agent for alzheimer's disease
11/03/2011	CA2793856A1 Tetrahydrobenzothiophene compound
11/03/2011	CA2793697A1 Inhibitors of phosphoinositide dependent kinase 1 (pdk1)
11/03/2011	CA2793616A1 New combination therapy in treatment of oncological and fibrotic diseases
11/03/2011	CA2792353A1 Methods and lipid compositions for promoting development of gut flora
11/03/2011	CA2791360A1 A pharmaceutical for preventing or treating an inner ear disorder
11/03/2011	CA2791020A1 [5,6] heterocyclic compound
11/03/2011	CA2738543A1 Precursor phase and its use in preparing magnesium tetrahydrate salt of an enantiomer of omeprazole
11/02/2011	EP2383341A1 Compositions and methods for siRNA inhibition of angiogenesis
11/02/2011	EP2383281A2 Prion-specific peptoid reagents
11/02/2011	EP2383272A1 Active blood coagulation factor inhibitor
11/02/2011	EP2383271A1 Aminoquinolones as GSK-3 Inhibitors
11/02/2011	EP2383270A1 Piperidine GPCR agonists
11/02/2011	EP2383269A2 Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
11/02/2011	EP2383268A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
11/02/2011	EP2383263A2 Novel thiazolidinedione derivative and use thereof
11/02/2011	EP2383262A1 Phenyl pyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
11/02/2011	EP2383255A1 New compounds, synthesis and use thereof in the treatment of pain
11/02/2011	EP2382993A1 Combination of drugs with protein-binding prodrugs
11/02/2011	EP2382992A1 Pharmaceutical composition for treating obesity or diabetes
11/02/2011	EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation

1 ... 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 ... 7860